Dorsomorphin dihydrochloride
Cat.No:ID2840 Solarbio
CAS:1219168-18-9
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Light yellow to yellow Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
PI3K/Akt/mTOR >
Dorsomorphin dihydrochlorideCAS:1219168-18-9
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Light yellow to yellow Solid
Qty:
Size:
CAS | 1219168-18-9 |
Name | Dorsomorphin dihydrochloride |
Molecular Formula | C24H25N5O·2HCl |
Molecular Weight | 472.41 |
Solubility | Soluble in Water |
Purity | ≥98% |
Appearance | Light yellow to yellow Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
MDL | MFCD11112197 |
SMILES | [H]Cl.[H]Cl.C12=C(C3=CC=NC=C3)C=NN1C=C(C4=CC=C(OCCN5CCCCC5)C=C4)C=N2 |
InChIKey | RJDVIJJQKMGPMV-UHFFFAOYSA-N |
InChI | InChI=1S/C24H25N5O.2ClH/c1-2-12-28(13-3-1)14-15-30-22-6-4-19(5-7-22)21-16-26-24-23(17-27-29(24)18-21)20-8-10-25-11-9-20;;/h4-11,16-18H,1-3,12-15H2;2*1H |
PubChem CID | 49761481 |
Target Point | AMPK |
Passage | PI3K/Akt/mTOR;Epigenetics |
Background | Dorsomorphin Dihydrochloride is a potent, selective and ATP-competitive AMPK inhibitor. |
Biological Activity | Dorsomorphin dihydrochloride是一种有效,选择性和 ATP 竞争性的 AMPK 抑制剂,Ki 为109±16 nM。[1-4] |
In Vitro | 在2DG应力下,用10μMDorsomorphin处理HT1080细胞2小时。免疫印迹分析显示,通过将HT1080细胞暴露于2DG,AMPK的催化α亚基的磷酸化水平增加,而当添加Dorsomorphin时,基础和2DG诱导的磷酸化水平明显降低。使用基于ELISA的测定系统测量细胞激酶活性证实,无论细胞培养条件如何,Dorsomorphin都会降低内源性AMPK活性[2]。 |
In Vivo | 在24小时内施用Dorsomorphin导致总血清铁浓度增加60%。因此,Dorsomorphin治疗可有效降低成人小鼠铁调素表达的基础水平并增加血清铁浓度[3]。 |
Cell Experiment | 在存在或不存在10mM 2DG或1μg/ mL衣霉素作为应激源的情况下,用不同浓度的Dorsomorphin(0,0.3,1,3,10μM),Versipelostatin和苯乙双胍处理HeLa和786-O细胞。 h在96孔板中。对于组合研究,在存在或不存在10mM 2DG的情况下,用各种浓度的UPR抑制剂处理786-O细胞24小时。然后用新鲜生长培养基替换培养基,并将细胞再培养15小时。随后,将MTT添加到培养基中,并确定每个孔的吸光度。对于在葡萄糖戒断条件下的活力测定,在存在或不存在葡萄糖的情况下,在12孔板中用不同浓度的Dorsomorphin和苯乙双胍处理HT1080细胞18小时,接种在96孔板中的生长培养基中,然后培养。再添加MTT前48小时。通过将来自未处理细胞的每个对照吸光度设定为100%来计算相对细胞存活率(一式四份测定的平均值±SD)。使用等效线法[2]分析药物组合在产生80%细胞生长抑制(IC80)的浓度下的作用。 |
Animal Experiment | 小鼠[3]在标准饮食中饲养的12周龄C57BL / 6小鼠通过尾静脉注射0.2g / kg葡聚糖或0.2g / kg铁 - 葡聚糖USP。葡聚糖仅注射载体,而铁 - 葡聚糖注射载体或Dorsomorphin(10mg / kg)。注射后1小时,杀死小鼠并将肝脏片段收集在500μLSDS-裂解缓冲液中并机械均化。通过SDS-PAGE分离20μL肝脏提取物并进行免疫印迹。使用来自机械均质化的小鼠肝脏的Trizol收获总RNA(注射后6小时,单次腹膜内剂量的Dorsomorphin(10mg / kg)或DMSO)。 |
Kinase Experiment | 将HT1080细胞接种在24孔板(每孔2×10 4个细胞)中,并在存在或不存在葡萄糖或10mM 2DG的情况下用Dorsomorphin处理2小时。通过在6孔板中转染质粒DNA(pAMPKα1-wt,pAMPKα1-D168A和pcFlag作为对照),在24孔板中接种并用UPR抑制剂处理来制备过表达野生型和显性失活AMPKα1的HT1080细胞。用细胞裂解缓冲液(20mM Tris-HCl,pH 7.5,250mM NaCl,10%甘油,0.5%NP-40,1mM EDTA,1mM EGTA,0.2mM PMSF,1μg/ mL胃蛋白酶抑制剂,0.5)裂解细胞。 μg/ mL亮抑酶肽,5mM NaF,2mM Na 3 Vo4,2mMβ-甘油磷酸盐,1mM DTT)。使用CycLex AMPK激酶测定试剂盒[2]测定对照样品(在正常生长条件下的载体或pcFlag)的相对AMPK激酶活性(重复测定的平均值±SD)。 |
Data Literature Source | [1]. Zhou G, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001 Oct; 108 (8) :1167-74. [2]. Saito S, et al. Compound C prevents the unfolded protein response during glucose deprivation through a mechanism independent of AMPK and BMP signaling. PLoS One. 2012; 7 (9) :e45845. [3]. Yu PB, et al. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol. 2008 Jan; 4 (1) :33-41. [4]. Zhang DY, et al. Role of autophagy and its molecular mechanisms in mice intestinal tract after severe burn. J Trauma Acute Care Surg. 2017 Oct; 83 (4) :716-724 |
Unit | Piece |
Specification | 5mg 10mM*1mL in Water |
是一种有效,选择性和 ATP 竞争性的 AMPK 抑制剂。
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Novel anti-obesity peptide (RLLPH) derived from hazelnut (Corylus heterophylla Fisch) protein hydrolysates inhibits adipogenesis in 3T3-L1 adipocytes by regulating adipogenic transcription factors and adenosine monophosphate-activated protein kinase (AMPK
Click to check >>Author:Wang J; Zhou M; Wu T; Fang L; Liu C; Min W.
IF:2.8000
Publish_to:J Biosci Bioeng
PMID:31630942